Abstract:Abstract Background Cystic fibrosis (CF) is a chronic multisystem disease with features including recurrent pulmonary infection, bronchiectasis, malnutrition, and alterations in drug metabolism which may discourage referral and listing for kidney transplantation. Although no specific renal phenotype is identified in CF, chronic kidney disease (CKD) occurs in young people and adults with CF with greater frequency than in the general population. The characteristics and outcomes of kidney transplantation in the CF population have not been previously described. Methods We used de-identified data supplied by the US Renal Data System (USRDS) to compare persons with end stage kidney disease (ESKD) with first kidney transplant, who did and did not have a diagnosis of CF. We compared demographic and clinical characteristics, mortality, patient survival, and death-censored graft survival using linear and logistic regression, multivariable logistic regression models, and Kaplan-Meier and log-rank tests with stratification/binning by propensity scores. Results Of those with dual diagnoses of CF and ESKD, half received a first kidney transplant. CF was independently associated with higher odds of receiving a living donor transplant. Those with a kidney transplant were younger than both those who did not have CF and those with CF without transplant and had higher odds of being female. Those with dual diagnoses of CF and ESKD had disproportionately lower odds of being identified as Black or African American relative to their representation in the population of all with CF and ESKD. Diabetes was more frequently a diagnosis and primary cause of ESKD in people with CF, but was approximately half as frequently the primary cause of ESKD as in those without CF. Complications of transplantation, particularly lung, were the second most frequent etiology of ESKD in people with CF. Overall survival with ESKD was 21.1 years for those with CF and 31.8 for those without CF. The survival benefit associated with transplant was 17.2 years for those with CF and 24.8 years for those without CF. Death censored median graft survival was significantly longer for those with CF, 20.4 vs 13.7 years. Conclusions CF is a chronic multisystem disease with features which may discourage referral and listing for kidney transplant. We used de-identified data from the USRDS datasets to describe the characteristics and outcomes of all unique individuals with the diagnosis of CF and first kidney transplant prevalent during the five-year period 2014 and 2018. Those with CF had similar odds to those without CF or receiving a first kidney transplant, and higher odds of receiving a living donor graft. Diabetes mellitus was significantly less frequently the primary cause of ESKD in those with CF and kidney transplant. Complications of solid organ transplant, particularly lung, were the second most frequent cause of ESKD in people with CF and kidney transplant. Median patient survival following the first kidney transplant was significantly shorter than for those who did not have CF, but was substantial, as was the survival advantage when compared to dialysis. Median graft survival was significantly longer for those with CF. It is our hope that this data will improve awareness of kidney disease in persons living with CF and their care teams, and encourage early referral to nephrology and transplant centers, and positive consideration of wait listing for kidney transplantation.

Peri‐operative and long‐term outcomes of kidney transplantation in patients with cystic fibrosis

Outcomes of Kidney Transplantation in Cystic Fibrosis

Risk Factors of Kidney Re-Transplantation Recipients and Graft Survival During the Long-Term Follow-Up

Combined Liver-Lung-Kidney Transplant in a Patient with Cystic Fibrosis

An aging population of patients with cystic fibrosis undergoes lung transplantation: An analysis of the ISHLT Thoracic Transplant Registry

End Stage Kidney Disease in Cystic Fibrosis

Short term results of kidney transplantation from donation after cardiac death compared with standard criteria donors

Perioperative outcomes of cardiac surgery in kidney and kidney-pancreas transplant recipients

Impact of suboptimal donor to suboptimal recipient kidney transplant on delayed graft function and outcome

Outcomes of single vs double lung retransplantation in patients with cystic fibrosis

The Relationship Between Kidney Function and Long-term Graft Survival After Kidney Transplant

Kidney Transplant Outcomes after Prolonged Delayed Graft Function

Impact of kidney transplant on post‐operative morbidity and mortality in patients with pre‐operative cardiac dysfunction

Survival Outcomes of Lung Transplant Recipients From Donors With Abnormal Kidney Function

Long‐term kidney transplant graft survival—Making progress when most needed

Long-term Kidney Transplant Survival Across the Globe

Recent contributions to transplantation at the University of Cincinnati

Outcome statistics of renal transplants with an emphasis on long‐term survival

Long-Term Outcomes of Nephrectomy Before Kidney Transplantation in Patients With Polycystic Kidney Disease

Impact of Machine Perfusion on Delayed Graft Function and Graft Survival from High-Risk Donors

Effect of perioperative management on early graft function in living donor paediatric kidney transplantation